Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1103 Spatial mapping and clinical significance of the CD39/CD73 adenosinergic pathway as a candidate immunotherapy target in non-small cell lung cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
